|1.||Ahn, Jin Hee: 5 articles (04/2014 - 08/2006)|
|2.||Cheon, Hyae Gyeong: 4 articles (02/2011 - 08/2006)|
|3.||Kim, Ki Young: 3 articles (02/2011 - 08/2006)|
|4.||Bae, Myung Ae: 2 articles (04/2014 - 03/2010)|
|5.||Kim, Sung Soo: 2 articles (08/2006 - 08/2006)|
|6.||Lee, Ji Eun: 1 article (05/2015)|
|7.||Zhang, Yu Lian: 1 article (05/2015)|
|8.||Han, Doo Hee: 1 article (05/2015)|
|9.||Rhee, Chae Seo: 1 article (05/2015)|
|10.||Kim, Dong Young: 1 article (05/2015)|
05/01/2015 - "The present study was aimed to investigate the effects of KR62980 on nasal symptoms and immunopathological profiles in allergic nasal mucosa in murine allergic rhinitis model. "
05/01/2015 - "Antiallergic Function of KR62980, a Peroxisome Proliferator-Activated Receptor-γ Agonist, in a Mouse Allergic Rhinitis Model."
03/15/2010 - "In conclusion, a novel PPARgamma ligand, KR62980, suppresses in vitro Th2 cell differentiation and attenuates in vivo OVA-induced airway inflammation, suggesting a beneficial role for KR62980 in the treatment of allergic asthma and allergic rhinitis."
|2.||Lung Neoplasms (Lung Cancer)
02/04/2011 - "Neuroprotective effects of KR-62980, a new PPARγ agonist, against chemical ischemia-reperfusion in SK-N-SH cells."
02/04/2011 - "In the present study, we investigated the effects of KR-62980, a new PPARγ agonist, and rosiglitazone on the neuronal cell death induced by chemical ischemia-reperfusion in SK-N-SH cells and their underlying molecular mechanisms. "
02/04/2011 - "Our results demonstrate that two PPARγ agonists, KR-62980 and rosiglitazone, inhibited chemical ischemia-reperfusion-induced neuronal cell death by PPARγ-mediated anti-apoptotic and anti-oxidant mechanisms related to PTEN suppression and ERK phosphorylation."
|4.||Breast Neoplasms (Breast Cancer)
08/28/2006 - "These results suggest that PPARgamma activation may result in the inhibition of cell proliferation and/or induction of cell differentiation depending on the type of PPARgamma agonists, and that KR-62980 may be useful in breast cancer therapy by inducing apoptosis."
08/28/2006 - "In the present study, we investigated the effects of two structurally different PPARgamma agonists, rosiglitazone and KR-62980 on MCF-7 breast cancer cells. "
04/01/2014 - "These results suggest that cICDH may be one of the targets of KR-62980 responsible for weight gain and adipogenesis."
08/14/2006 - "Treatment of high fat diet-induced C57BL/6J mice with KR-62980 for 14 days reduced plasma glucose levels with little side effects with regard to weight gain, cardiac hypertrophy and hepatotoxicity. "
|4.||Interleukin-17 (Interleukin 27)
|6.||Peroxisome Proliferator-Activated Receptors (PPAR)
|7.||Interleukin-5 (Interleukin 5)
|9.||Immunoglobulin E (IgE)